Abstract
Dietary fiber functions as a prebiotic to determine the gut microbe composition. The gut microbiota influences the metabolic functions and immune responses in human health. The gut microbiota and metabolites produced by various dietary components not only modulate immunity but also impact various organs. Although recent findings have suggested that microbial dysbiosis is associated with several respiratory diseases, including asthma, cystic fibrosis, and allergy, the role of microbiota and metabolites produced by dietary nutrients with respect to pulmonary disease remains unclear. Therefore, we explored whether the gut microbiota and metabolites produced by dietary fiber components could influence a cigarette smoking (CS)-exposed emphysema model. In this study, it was demonstrated that a high-fiber diet including non-fermentable cellulose and fermentable pectin attenuated the pathological changes associated with emphysema progression and the inflammatory response in CS-exposed emphysema mice. Moreover, we observed that different types of dietary fiber could modulate the diversity of gut microbiota and differentially impacted anabolism including the generation of short-chain fatty acids, bile acids, and sphingolipids. Overall, the results of this study indicate that high-fiber diets play a beneficial role in the gut microbiota-metabolite modulation and substantially affect CS-exposed emphysema mice. Furthermore, this study suggests the therapeutic potential of gut microbiota and metabolites from a high-fiber diet in emphysema via local and systemic inflammation inhibition, which may be useful in the development of a new COPD treatment plan.
Similar content being viewed by others
Introduction
Chronic obstructive pulmonary disease (COPD) is a progressive respiratory disease characterized by persistent airflow obstruction and abnormal inflammatory responses1,2. Cigarette smoking (CS) is a major risk factor for respiratory and systemic diseases including COPD, cardiovascular disease, and cancer due to the pathogenicity of circulating toxic constituents, metabolites and their associated inflammatory response3,4. Moreover, CS can directly or indirectly influence the microbiome through immune homeostasis, biofilm formation, oxygen deprivation, and other potential mechanisms5,6.
Many studies have revealed that the gut microbial community (gut microbiota) affects metabolic function, inflammation, and physiological processes that modulate local and systemic inflammatory responses. Several scientific findings have highlighted the correlation between the gut microbiota and lung immunity in the gut-lung axis7,8. The constituents of the gut microbiota change in response to dietary nutrients, which are associated with immune responses and homeostasis. This interaction between gut microbiota and nutrients is also associated with respiratory diseases, mostly studies in asthma and allergy, along with gut microbiome dysbiosis9,10. Among nutrients working as prebiotics, dietary fibers are associated with a more diversified gut microbiota that releases metabolites with multiple functions in the host, and they are known to reduce the risk of chronic inflammatory diseases.
The metabolites produced by the gut microbiome regulate the host’s immune system and influence various organs. In accordance with these findings, the physiological influence of gut microbiota alteration and subsequent nutrient variation are governed by the differences in microbial metabolome profiles. Furthermore, metabolic byproducts derived from the bacterial fermentation of dietary fibers are important local and systemic signaling molecules that sustain immune and tissue homeostasis11. Among them, short-chain fatty acids (SCFAs) are metabolites that have been studied extensively, and they have immunomodulatory functions within the diverse aspects of host physiology12. SCFAs are produced by the fermentation of dietary fiber by specific microbes in the intestinal colon and exhibit anti-inflammatory properties13,14. Bile acids (BAs) are essential components of the digestive system and it reflects the amount of those escaping extraction from the portal blood15. Interestingly, they have also been associated with lung injury16,17,18,19 and lung inflammation20,21,22. Sphingolipids (SLs) can be rapidly generated or converted into each other, and they play pivotal roles in various cellular processes23. Moreover, SLs are increasingly recognized as critical mediators in major pulmonary diseases and are associated with COPD phenotypes23,24. Among them, ceramide, an intermediate product of sphingomyelin (SM) metabolism, is associated with COPD25 and the inflammatory response26.
In accordance with these findings, gut microbiota, metabolites, and nutrients are closely associated with the increased incidence of various inflammatory diseases. We previously performed a study to show that fecal microbiota transplantation and high fiber diet attenuated emphysema development and changed the gut microbiota composition27. Despite the growing knowledge on the immunomodulatory effects of the gut microbiota on systemic diseases, microbiota-metabolite interaction induced by dietary nutrients in the gut-lung axis in emphysema needs to be investigated further. Therefore, in this study, we investigated the effect of high-fiber diet on emphysema and the impact of gut microbiota-metabolite interaction by different types of dietary fiber compositions in a CS-exposed emphysema model. Furthermore, the relationship between the gut microbiota and metabolites was investigated based on the high-fiber diet components by analyzing the altered microbiota and metabolome profiles in a CS-exposed emphysema model.
Results
Dietary fiber improves alveolar destruction and inflammation during emphysema progression
To determine whether dietary fiber influence emphysema, the effect of high-fiber dietary modification on pulmonary inflammatory responses in CS-exposure-induced emphysema was first analyzed. Histological analysis showed that alveolar destruction and airspace enlargement were most severe in the emphysema group and less severe in the emphysema with high-fiber diet group (Fig. 1A). This observation was confirmed by the mean linear intercept (MLI) measurement, which was significantly lower in the emphysema with high-fiber diet group than in the emphysema group (Fig. 1B). The alveolar structures and forms of histological emphysema were more improved in the high-pectin diet group compared to those in the high-cellulose diet group (Fig. 1A,B). Moreover, the bronchoalveolar lavage fluid (BALF) for immune infiltration to the inflammatory response was analyzed. Inflammatory cell infiltration was higher in the BALF of all CS-exposed groups (Fig. 1C). This inflammation was characterized by increased macrophage infiltration, which was the highest in the emphysema group. The number of macrophages and neutrophils in the BALF was significantly lower in the emphysema with high-fiber diet group than in the emphysema group (Fig. 1D). The results of the analysis of the inflammatory cells from the BALF indicated a marginal decrease in the number of macrophages and neutrophils in the high-pectin diet group compared to the high-cellulose diet group. Moreover, the inflammatory cytokine levels in the BALF and serum were further evaluated. The levels of interleukin-6 (IL-6) and interferon-γ (IFN-γ) were significantly increased in the BALF and serum of the emphysema group, which is presumably associated with increased macrophage infiltration. The IL-6 and IFN-γ levels in the BALF and serum were lower in the high-pectin diet group than those in the emphysema group (Fig. 1E,F). The inflammatory cytokine levels in the BALF and serum were lower in the high-pectin diet group than those in the high-cellulose diet group. In accordance with the above results, the mRNA expression levels of representative pro-inflammatory mediators and immune modulators, including IFN-γ, IL-1β, IL-6, IL-8, IL-18, IRF-5, MMP-12, TNF-α, TGF-β, and cathepsin S, were lower in the emphysema with high-fiber diet group than those in the emphysema group. The expression of inflammatory markers was lowest in the high-pectin diet group than in all other groups (Fig. 1G). These results indicated that the high-fiber diet attenuated the pathological changes during emphysema progression and influenced an inflammatory response associated with CS-exposed emphysema. Moreover, less inflammation was observed in emphysema mice supplemented with fermentable fiber content (pectin) than in emphysema mice supplemented with non-fermentable fiber content (cellulose). Furthermore, these results indicate that a prebiotic high-fiber diet helps to prevent CS-exposure-induced emphysema progression and suggests that immune modulation by dietary fibers can attenuate the local and systemic effects of emphysema.
Dietary fiber modulates the microbial community structure
Diet has a major impact on gut microbiota composition, diversity, and richness. Different components of diet shape the gut bacterial communities. Considering that different dietary fiber components have different impacts on emphysema, different types of dietary fiber components were hypothesized to influence the microbial composition and are related to the immunity in the gut-lung axis. To confirm this hypothesis, the microbial analysis of the fecal samples was performed. A principal coordinate analysis based on the relative abundance of genera represents the distinct fecal microbial community structures. Different components of dietary fiber were significantly associated with different microbial community structures in the gut (Fig. 2A). Moreover, changes in the microbial composition of the fecal samples were analyzed using the linear discriminant analysis effect size (LEfSe) cladogram (Fig. 2B) and histogram (Fig. S1). Furthermore, the differences in the microbial composition were evaluated based on the phylum, class, and family levels (Fig. 3A-C). The Bacteroidetes phylum level was the most abundant in the emphysema with high-pectin diet group compared to the other groups (Fig. 3A). At the family level, pyrosequencing showed that the emphysema group had increased Lactobacillaceae, Defluviitaleaceae, and Oscillospiraceae family members compared to the control group. On the other hand, the high-fiber diet group had decreased amounts of Lactobacillaceae, Defluviitaleaceae, and Oscillospiraceae compared to the emphysema group and Lactobacillaceae and Defluviitaleaceae family levels were the lowest in the high-pectin diet group (Fig. 3C). The emphysema with high-cellulose diet group had the highest abundance of the Verrucomicrobia phyla (genus Akkermansia) and Alphaproteobacteria class (Fig. 3A). Furthermore, within the Alphaproteobacteria class, the Rhodospirillaceae family was observed only in the high-cellulose diet group (Fig. 3C). Based on these findings, it is observed that different types of dietary fiber components can regulate the changes in the gut microbial composition. These results provide a mechanistic insight into the protective nature of dietary-modulated microbiota during the progression of emphysema and suggest a beneficial effect on dietary-microbiota-immunity.
Dietary fiber regulates the global metabolomic profile
To confirm the association between metabolites and emphysema or fiber, global metabolomic profiles were analyzed using MetaboAnalyst 4.0. The four groups in the feces, serum, and lung were classified based on the partial least squares discriminant analysis (PLS-DA). The optimal number of metabolic features for classification was selected based on the best predictive ability of the model. Five unidentified metabolites in the feces, three unidentified metabolites and L-phenylalanine in the serum, and one unidentified metabolite and AMP in the lung were used as basis for the classification, respectively (Fig. S2). A pathway analysis was performed using a KEGG library with significantly changed metabolic features. Based on the P value < 0.05 in the pathway analysis and impact value threshold (0.10), various pathways induced by CS-exposed emphysema and fiber diet were identified. The comparison between the two groups was further analyzed in three ways: (1) control vs. emphysema, (2) emphysema vs. emphysema with high-cellulose diet, and (3) emphysema vs. emphysema with high-pectin diet for feces, affected by microbiota ecology primarily. β-alanine metabolism and histidine metabolism had the highest impact (0.40) on grouping control and emphysema. Several common pathways were significantly affected by high-cellulose and -pectin diet. Linoleic acid, primary BA synthesis, phenylalanine, tyrosine and tryptophan biosynthesis, steroid hormone biosynthesis, and SL metabolisms exhibit a significant effect. Among them, linoleic acid metabolism showed the highest impact value (1.0) in both comparisons (Fig. 4), and primary BA biosynthesis had the most significant impact with a P value of 2.28 × 10–6. Linoleic acid metabolism and d-glutamate metabolism showed the highest impact values (1.0) in the lungs based on the pathway topology analysis (Fig. S3). Caffeine metabolism and linoleic acid metabolism had the highest impact in the serum. Arachidonic acid metabolism was the pathway with significant impact in both feces (Fig. 4) and serum (Fig. S4). The metabolic patterns provide an overview of the metabolic differences in the four groups. The top metabolites representing the differences in the feces, lung, and serum are visually illustrated by heatmaps (Fig. S5). Furthermore, the targeted metabolites were different in the four groups.
Dietary fiber regulates targeted metabolomic profiles
Further analysis with targeted metabolomic profiles was performed for SCFAs, BAs, and SLs, and detailed results were described in the supplementary results. Overall, the acetate, propionate, and butyrate concentrations were the lowest in the emphysema group compared to the other groups. The local concentrations of SCFAs (acetate, propionate, and butyrate) were notably higher in the emphysema with high-fiber (cellulose and pectin) diet group than in the emphysema group. The SCFA (acetate, propionate, and butyrate) concentrations were increased in the high-pectin diet group compared to the high-cellulose diet group (Fig. 5). The results are similar to those previously reported28. The primary BA concentrations, such as cholic acid (CA) and chenodeoxycholic acid (CDCA), in the feces were higher in the control group than in the emphysema group (Fig. 6A). The secondary BA concentrations, such as deoxycholic acid (DCA) and lithocholic acid (LCA), in the feces, serums, and lung tissues were higher in the emphysema group than in the control group (Fig. 6A-C). Interestingly, the CA, CDCA, and ursodeoxycholic acid (UDCA) concentrations in the feces were higher in the high-pectin diet group than in the emphysema group. Meanwhile, the CDCA, DCA, LCA, CA, and UDCA concentrations in the lung tissues and serums were higher in the emphysema group than in the other groups (Fig. 6). These results are similar to those previously reported in respiratory disease29.
Discussion
The gut microbiota, via various dietary nutrients, is involved in the production of metabolites that play a major role in human immunity. Metabolites like SCFAs significantly influence systemic immunity and the circulatory systems30. Therefore, it is reasonable that gut microbiota dysbiosis via malnutrition or unhealthy diet is associated with dysregulated inflammation affecting autoimmune or respiratory diseases31. However, the interactions between dietary fiber components and the regulatory mechanisms of respiratory diseases have not been investigated.
This study explored whether dietary fibers acting as prebiotics directly interact with gut microbes and play a role in the production of key metabolites, including SCFAs, BAs, and SL. This study also discussed how dietary fibers impact gut microbial ecology, host physiology, and immunity. The therapeutic potential of modulating gut microbiota and metabolites by a high-fiber diet was investigated in a CS-exposed emphysema model. CS is a major risk factor for COPD, which is impacted by the significant pathogenicity of circulating toxic constituents or metabolites of absorbed CS4,32. A CS-induced emphysema model was used based on general pathologies and mechanisms of human emphysema. In this model, a high-cellulose and high-pectin diet significantly suppressed the inflammation and attenuated the pathological changes in emphysema mice. The number of immune cells, macrophages, and neutrophils was lower in the high-fiber (cellulose and pectin) diet group than in the emphysema group. These results confirm that inflammatory cytokine levels and mRNA levels were decreased in the high-fiber (cellulose and pectin) diet group and that dietary fiber strongly inhibits inflammation. The effect of high fiber diet on lung function and COPD is also proven in epidemiologic studies33,34, although the underlying mechanism is not clear. Extensive studies have found that the gut microbiota is crucial in maintaining host homeostasis via immune system interactions35,36. Low gut microbial diversity is associated with increased risk of lung disease37. The interactions between dietary fiber components and gut microbial communities were investigated in an emphysema model. The present study showed that the emphysema group had increased Lactobacillaceae, Defluviitaleaceae, and Oscillospiraceae family members compared to the control group. The high-cellulose and high-pectin diet groups had lower Lactobacillaceae, Defluviitaleaceae, and Oscillospiraceae family members compared to the emphysema group. The increase of Lactobacillaceae in COPD was also identified in human studies and it was also associated with local inflammation38,39. The role of the Defluviitaleaceae and Oscillospiraceae family members (Clostridia class) in the respiratory diseases has not yet been investigated, our study suggests the necessity to further confirm their roles. Interestingly, the Rhodospirillaceae family (Alphaproteobacteria class) was observed only in the high-cellulose diet group. Alphaproteobacteria is a diverse class of organisms within the Proteobacteria phylum with many biological roles and cellulose usually increases their numbers40,41. Bacteroidetes are major producers of SCFAs, and the proportion of Bacteroidetes is significantly decreased in cases of COPD42. Accordingly, the emphysema with high-pectin diet group had the highest abundance of the Bacteroidetes phyla compared to the other groups in this study. The emphysema with high-cellulose diet group had the highest abundance of the Verrucomicrobia phyla (genus Akkermansia) and the Alphaproteobacteria class (phylum Proteobacteria), which has many important biological roles. These data indicate that both pectin and cellulose supplementation modulates the microbial community structures and effectively alter the composition of the gut microbiota. The protective effects of high-fiber diet against emphysema progression may be influenced by the direct interactions of microbiota, dietary fiber and immune system.
Various metabolites have been extensively investigated in terms of their beneficial immunomodulatory roles43,44. Specifically, SCFAs reduce colitis by inducing colonic regulatory T cells45 and driving colonocytes towards mitochondrial beta oxidation of fatty acids46. SCFAs also prevent asthma pathology28. Malnutrition adversely affects the gut microbiota composition and decreases the production of physiologically active byproducts that are key driving factors in the prevalence of inflammatory disease44. Previous studies have reported that dietary fiber-induced microbial SCFAs not only suppress the ILC2-dependent airway inflammation47 but also modulate immunity28. Similarly, in the present study, the feces from the emphysema with high-fiber (cellulose and pectin) diet group were significantly enriched with acetate, propionate, and butyrate and had large alterations in the gut microbiota. Moreover, the SCFAs concentrations were increased in the high-pectin diet group than in the high-cellulose diet group. Moreover, the valeric acid and 2,3,4-methylvaleric acid concentrations were higher in emphysema mice with high-pectin diet than in emphysema mice. We confirmed that high-pectin diet was associated with an abundance of SCFA with anti-inflammatory properties in an emphysema model. These results show that different types of dietary fiber ingredients (fermentable or non-fermentable) induce different changes in metabolite levels and regulate the levels of different SCFA metabolites. In addition, the protective effects of dietary fiber induced SCFAs through the interactions between the microbiota and immune system may inhibit the progression of emphysema.
Among the various endogenous metabolites produced by host-gut microbiota metabolism, BAs are gaining increased attention48. They serve as nutrient signaling hormones, play a role in inflammation, and are associated with COPD and lung disease inflammation16,17,18,19,20. We also explored the regulation of BA metabolites by different dietary fiber components in an emphysema model. In this study, we showed that the DCA and LCA concentrations in the feces, serums, and lung were higher in emphysema mice than in control mice. Moreover, the DCA, LCA, and CDCA concentrations in serums and lung were lower in the high-pectin diet and high-cellulose diet groups than in the emphysema group. The secondary BA concentrations (DCA, UDCA, and LCA) in the feces were higher in the high-pectin diet group compared to other groups. A previous review article suggested that dietary fibers bind conjugated primary BAs and may serve as a platform for gut bacteria, thus leading to deconjugation which is a perquisite for biotransformation to secondary BAs49. Therefore, this indicates that different types of dietary fiber components can affect various BA metabolites. Moreover, this study suggests that BAs, via dietary-metabolic regulation, are associated with local and systemic inflammatory responses in an emphysema model.
SLs are constituents of cellular membranes and participate in cellular responses to stress, thereby ensuring cell survival. Therefore, the proper functioning of the SL metabolic pathway is essential for cellular homeostasis50. Moreover, the role of SLs as mediators of inflammation may have significant implications in a range of pulmonary diseases in which inflammation is a central process of the pathogenesis51. The extensive alterations in SL metabolism induced by CS exposure are controlled by a complex regulatory program, which, concomitantly, may also mediate other adaptive and destructive tissue responses. Moreover, changes in SL metabolism are intrinsic to the broad response of the tissue to CS exposure and dietary fiber intake, including oxidative stress and xenobiotic stress responses, immune response, and other metabolic alterations. As smoking-related inflammation and a high-fiber diet impact SL metabolism, the association between SLs and inflammation in COPD can be determined. Further metabolomics studies are needed to investigate the potential diagnostic and therapeutic candidates in emphysema.
The fatty acids including alpha-linolenic acid and linoleic acid are essential for humans52. Omega-3 fatty acids, such as plant-derived alpha-linolenic acid and its forms primarily found in fish, give rise to anti-inflammatory and pro-resolving mediators53. Previous studies have reported that the higher dietary intake of omega-3 fatty acids leads to the decrease in cardiovascular risk/atherosclerosis54, autoimmune disease activity55, morbidity in asthma56, COPD57, and other chronic diseases58. Global metabolomics profile analysis revealed that the linoleic acid metabolism pathway had the highest impact on the emphysema with high-cellulose and high-pectin diet groups. Therefore, these results suggest that anti-inflammatory mechanisms including the linoleic acid pathway prevent the COPD development.
These results suggested that the protection exhibited by high-cellulose or high-pectin diet against emphysema may depend on the microbiota-metabolism-immunity interactions. However, the complex relationship among these biological systems and prebiotics in emphysema needs further investigation. Additionally, the bioavailability of nutrients and bioactive compounds in fruits and vegetables is an extremely important area of nutrition and medical research. Water-soluble dietary fibers can impair the bioavailability of beta-carotene in the gastrointestinal tract59,60,61,62. Thus, further research is required to understand the dietary-fiber-associated bioavailability and functions of carotenoids.
The important regulatory roles of naturally occurring deuterium in fundamental biological processes and the antitumor effect of deuterium depletion have been demonstrated in multiple studies63,64,65,66,67. Deuterium depletion occurs through returning low deuterium ketogenic propionic acid to the circulation for terminal oxidation into CO2 and deuterium-depleted metabolic water in the mitochondria/peroxisomes of host cells68. Hence, the correlation among emphysema, deuterium-depleted metabolites, and metabolizing organisms in the gut microbiome-SCFAs digesting dietary fiber needs to be investigated further. New insights into the role of deuterium depletion in emphysema may facilitate the development of novel emphysema treatments.
The findings of this study indicate that compositions of the gut microbiota and metabolites can be modulated using a high-fiber diet, consequently attenuating emphysema development via inhibition of local and systemic inflammation, which may provide future therapeutic applications for preventing or delaying emphysema progression.
Materials and methods
Emphysema mouse model
Female C57BL/6 mice (8 weeks old) were purchased from Orient Bio Inc. (Seongnam, Republic of Korea) and maintained at room temperature (RT, 25 °C) in a 12/12-h light/dark cycle. The animal model of emphysema was exposed with CS according to a previously reported protocol27. This study complied with guidelines of the 8th edition of the Guide for the Care and Use of Laboratory Animals. All animal experiments were approved by the Institutional Animal Care and Use Committee of Asan Medical Center, Seoul, Republic of Korea (2019-14-069), and were performed according to the ARRIVE (Animal Research: Reporting In vivo Experiments) guidelines69.
Diet modifications
The animals were randomly divided into four groups (n = 6 mice/group): Group I (control group, Ctrl), Group II (emphysema group, E, CS exposure only), Group III (E + C, CS exposure with a high-cellulose diet), and Group IV (E + P, CS exposure with a high-pectin diet). The mice were fed ad libitum with the standard AIN-76A diet supplied by Daehan Biolink Co., LTD (Chungbuk, Republic of Korea). The two types of dietary modifications based on the standard AIN 76A diet were as follows: the high-cellulose diet (20% cellulose), which was modified with cellulose from vegetable supplement, and the high-pectin diet (20% pectin), which was modified with pectin from citrus supplement. Groups I and II were given the standard AIN-76A diet for 4 weeks. Group III and IV were given the AIN-76A diet for 1 week and were administered with a modified diet for the last 3 weeks of the experiment period.
Preparation of samples
After 4 weeks, the animals were anesthetized through isoflurane inhalation, and the blood samples were collected by heart puncture. The trachea was catheterized and perfused with 1.5 mL of PBS. The cellular and liquid fractions of the BALF were separated by centrifugation at 2200 rpm for 5 min at 4 °C. The cell pellet was suspended in PBS, seeded onto a slide, and stained with Diff-Quick (Sysmex, Kobe, Japan). Inflammatory cells were observed under a light microscope (Leica, USA). All specimens were collected, fixed, immediately frozen, and stored at − 80 °C until analysis.
Histomorphological assessment
The left lung was inflated with 0.5% low-melting-point agarose at a pressure of 15 cm H2O. The left lobe was embedded in paraffin, cut into 5-μm-thick sections, and stained with hematoxylin and eosin. Emphysematous changes were observed under a light microscope (Leica, USA) and were evaluated by measuring the MLI. MLI is a measurement of the mean interalveolar septal wall distance determined by the number of interruptions in 1 mm lines of the alveolar wall. Four lines were drawn in each field, and at least five random fields were examined per mouse.
Cytokine level quantification
The levels of the cytokines IL-6 and IFN-γ in the BALF and serum were measured using a commercially available ELISA kit (R&D Systems, Minneapolis, MN, USA) based on the manufacturer’s instructions.
Quantitative real-time PCR analysis
Total RNA was extracted from lung tissues using TRIzol reagent (Thermo Fisher Scientific, Waltham, MA, USA) in accordance with the manufacturer’s protocol as previously described27. Transcription levels were measured using real-time PCR with sequence-specific primers for IFN-γ, IL-1β, IL-6, IL-8, IL-18, MMP-12, TNF-α, TGF-β, cathepsin S, and IRF-5 (Table S1).
DNA extraction and microbiota bacterial composition analysis
DNA was extracted from fecal samples using a DNA isolation kit (MO BIO, Carlsbad, CA, USA) in accordance with the manufacturer’s instructions. DNA was amplified with 16S_V3_F and 16S_V4_R primers specific to the V3-V4 hypervariable regions of the 16S rDNA gene (Supplementary Table S1). The libraries were prepared using PCR products in accordance with the MiSeq System Guide (Illumina, USA) and quantified using the QIAxpert System (QIAGEN, Germany). Each amplicon was quantified, and an equimolar ratio was pooled and sequenced on a MiSeq (Illumina) in accordance with the manufacturer’s instructions. Microbiota bacterial composition analysis was performed, following the procedure previously described27.
Quantitative metabolome measurement
Standard metabolites and internal standards were purchased from Sigma-Aldrich (St. Louis, MO, USA), and all solvents were purchased from J. T. Baker (Center Valley, PA, USA). The SCFA metabolites in feces and BA metabolites were measured using a previously described procedure70,71. Mouse serum (20 µL) was mixed well with 500 μL of cold acetonitrile and 50 μL of internal standard solution (50 μL of 1 μM cholic acid-d5 solution). For the SL metabolites, the Folch method was used to extract the lipids from 20 to 30 mg of mouse lung after adding 50 μL of internal standard solution (50 nM of C17 ceramide solution)72. For the 30 μL of mouse serum, the lipids was extracted using the Bligh and Dyer method after adding the internal standard solution73. The organic layer containing sphingolipids was dried using a vacuum centrifuge and stored at − 20 °C until liquid chromatography-tandem mass spectrometry (LC–MS/MS) analysis. The dried matter from the feces, serum, and lung was stored at − 20 °C and reconstituted with methanol (MeOH) prior to LC–MS/MS analysis for all the analyses performed. Furthermore, the samples were analyzed using a LC–MS/MS system equipped with a 1290 HPLC (Agilent, Waldbronn, Germany) and QTRAP5500 mass spectrometry (AB Sciex, Toronto, Canada). Additional methods are described in the data supplement.
Global metabolome profiling
The metabolites were extracted using conventional liquid–liquid extraction procedures72,73. Briefly, 3–4 volumes of chloroform/methanol (2/1, v/v) were added to freeze-dried feces, lung, and serum and then centrifuged for 15 min. Nonpolar metabolites containing lipids were collected from the lower organic phase, and polar metabolites were collected in the upper aqueous phase. The LC–MS was equipped with Ultimate3000 (Dionex) and Orbitrap XL (Thermo Fisher). A reverse phase column (Pursuit 5; 150 × 2.0 mm) and HILIC (HILIC Plus; 100 × 2.1 mm) were used for nonpolar and polar metabolites, respectively. LC–MS analysis was conducted for each sample solution in positive and negative ion modes. Data normalization was performed using log transformation and auto-scaling. Metabolite features, including neutral mass and retention time values, were determined using the Compound Discoverer 2.1. Moreover, metabolite features showing statistically significant changes (P < 0.05) were chosen and identified using the KEGG database (http://www.kegg.jp/kegg/kegg1.html) with a mass accuracy of 10 ppm. Statistical analyses including the PLS-DA were conducted using MetaboAnalyst 4.0.
Statistical analysis
Data were analyzed using the Kruskal–Wallis H test, Mann–Whitney U test, and one-way ANOVA followed by Tukey’s test with the IBM SPSS version 25 (https://www.ibm.com/analytics/spss-statistics-software). All values were expressed as the mean ± standard error (SE). Statistical significance was set at P < 0.05.
References
Vogelmeier, C. F. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am. J. Respir. Crit. Care Med. 195, 557–582. https://doi.org/10.1164/rccm.201701-0218PP (2017).
Chronic obstructive pulmonary disease. Nat. Rev. Dis. Primers 1, 15079. https://doi.org/10.1038/nrdp.2015.79 (2015).
Barnes, P. J. Chronic obstructive pulmonary disease. N. Engl. J. Med. 343, 269–280. https://doi.org/10.1056/NEJM200007273430407 (2000).
Arcavi, L. & Benowitz, N. L. Cigarette smoking and infection. Arch. Intern. Med. 164, 2206–2216. https://doi.org/10.1001/archinte.164.20.2206 (2004).
Macgregor, I. D. Effects of smoking on oral ecology. A review of the literature. Clin. Prev. Dent. 11, 3–7 (1989).
Huang, C. & Shi, G. Smoking and microbiome in oral, airway, gut and some systemic diseases. J. Transl. Med. 17, 225. https://doi.org/10.1186/s12967-019-1971-7 (2019).
Marsland, B. J., Trompette, A. & Gollwitzer, E. S. The gut-lung axis in respiratory disease. Ann. Am. Thorac. Soc. 12(Suppl 2), S150-156. https://doi.org/10.1513/AnnalsATS.201503-133AW (2015).
Ubags, N. D. J. & Marsland, B. J. Mechanistic insight into the function of the microbiome in lung diseases. Eur. Respir. J. https://doi.org/10.1183/13993003.02467-2016 (2017).
Turnbaugh, P. J., Backhed, F., Fulton, L. & Gordon, J. I. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3, 213–223. https://doi.org/10.1016/j.chom.2008.02.015 (2008).
Wood, L. G., Shivappa, N., Berthon, B. S., Gibson, P. G. & Hebert, J. R. Dietary inflammatory index is related to asthma risk, lung function and systemic inflammation in asthma. Clin. Exp. Allergy 45, 177–183. https://doi.org/10.1111/cea.12323 (2015).
Maslowski, K. M. et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461, 1282–1286. https://doi.org/10.1038/nature08530 (2009).
Koh, A., De Vadder, F., Kovatcheva-Datchary, P. & Backhed, F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165, 1332–1345. https://doi.org/10.1016/j.cell.2016.05.041 (2016).
McNabney, S. M. & Henagan, T. M. Short chain fatty acids in the colon and peripheral tissues: a focus on butyrate, colon cancer, obesity and insulin resistance. Nutrients https://doi.org/10.3390/nu9121348 (2017).
Canani, R. B. et al. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J. Gastroenterol. 17, 1519–1528. https://doi.org/10.3748/wjg.v17.i12.1519 (2011).
Kim, M. J. & Suh, D. J. Profiles of serum bile acids in liver diseases. Korean J. Intern. Med. 1, 37–42. https://doi.org/10.3904/kjim.1986.1.1.37 (1986).
Zecca, E. et al. Bile acid pneumonia: A “new” form of neonatal respiratory distress syndrome?. Pediatrics 114, 269–272. https://doi.org/10.1542/peds.114.1.269 (2004).
Su, K. C. et al. Bile acids increase alveolar epithelial permeability via mitogen-activated protein kinase, cytosolic phospholipase A2, cyclooxygenase-2, prostaglandin E2 and junctional proteins. Respirology 18, 848–856. https://doi.org/10.1111/resp.12086 (2013).
Wu, Y. C. et al. Bile acid aspiration in suspected ventilator-associated pneumonia. Chest 136, 118–124. https://doi.org/10.1378/chest.08-2668 (2009).
Savarino, E. et al. Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients. Eur. Respir. J. 42, 1322–1331. https://doi.org/10.1183/09031936.00101212 (2013).
Perng, D. W. et al. Exposure of airway epithelium to bile acids associated with gastroesophageal reflux symptoms: a relation to transforming growth factor-beta1 production and fibroblast proliferation. Chest 132, 1548–1556. https://doi.org/10.1378/chest.07-1373 (2007).
D’Ovidio, F. et al. The effect of reflux and bile acid aspiration on the lung allograft and its surfactant and innate immunity molecules SP-A and SP-D. Am. J. Transpl. 6, 1930–1938. https://doi.org/10.1111/j.1600-6143.2006.01357.x (2006).
D’Ovidio, F. et al. Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation. J. Thorac. Cardiovasc. Surg. 129, 1144–1152. https://doi.org/10.1016/j.jtcvs.2004.10.035 (2005).
Yang, Y. & Uhlig, S. The role of sphingolipids in respiratory disease. Ther. Adv. Respir. Dis. 5, 325–344. https://doi.org/10.1177/1753465811406772 (2011).
Bowler, R. P. et al. Plasma sphingolipids associated with chronic obstructive pulmonary disease phenotypes. Am. J. Respir. Crit. Care Med. 191, 275–284. https://doi.org/10.1164/rccm.201410-1771OC (2015).
Nobakht, M. G. B. F., Aliannejad, R., Rezaei-Tavirani, M., Taheri, S. & Oskouie, A. A. The metabolomics of airway diseases, including COPD, asthma and cystic fibrosis. Biomarkers 20, 5–16. https://doi.org/10.3109/1354750X.2014.983167 (2015).
Bodas, M., Pehote, G., Silverberg, D., Gulbins, E. & Vij, N. Autophagy augmentation alleviates cigarette smoke-induced CFTR-dysfunction, ceramide-accumulation and COPD-emphysema pathogenesis. Free Radic. Biol. Med. 131, 81–97. https://doi.org/10.1016/j.freeradbiomed.2018.11.023 (2019).
Jang, Y. O. et al. Fecal microbial transplantation and a high fiber diet attenuates emphysema development by suppressing inflammation and apoptosis. Exp. Mol. Med. https://doi.org/10.1038/s12276-020-0469-y (2020).
Trompette, A. et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 20, 159–166. https://doi.org/10.1038/nm.3444 (2014).
Aldhahrani, A., Verdon, B., Ward, C. & Pearson, J. Effects of bile acids on human airway epithelial cells: implications for aerodigestive diseases. ERJ Open Res. https://doi.org/10.1183/23120541.00107-2016 (2017).
Anand, S. & Mande, S. S. Diet, microbiota and gut-lung connection. Front. Microbiol. 9, 2147. https://doi.org/10.3389/fmicb.2018.02147 (2018).
Ege, M. J. et al. Exposure to environmental microorganisms and childhood asthma. N. Engl. J. Med. 364, 701–709. https://doi.org/10.1056/NEJMoa1007302 (2011).
Cruickshank-Quinn, C. I. et al. Transient and persistent metabolomic changes in plasma following chronic cigarette smoke exposure in a mouse model. PLoS ONE 9, e101855. https://doi.org/10.1371/journal.pone.0101855 (2014).
Kan, H., Stevens, J., Heiss, G., Rose, K. M. & London, S. J. Dietary fiber, lung function, and chronic obstructive pulmonary disease in the atherosclerosis risk in communities study. Am. J. Epidemiol. 167, 570–578. https://doi.org/10.1093/aje/kwm343 (2008).
Varraso, R., Willett, W. C. & Camargo, C. A. Jr. Prospective study of dietary fiber and risk of chronic obstructive pulmonary disease among US women and men. Am. J. Epidemiol. 171, 776–784. https://doi.org/10.1093/aje/kwp455 (2010).
Hooper, L. V., Littman, D. R. & Macpherson, A. J. Interactions between the microbiota and the immune system. Science 336, 1268–1273. https://doi.org/10.1126/science.1223490 (2012).
Shreiner, A. B., Kao, J. Y. & Young, V. B. The gut microbiome in health and in disease. Curr. Opin. Gastroenterol. 31, 69–75. https://doi.org/10.1097/MOG.0000000000000139 (2015).
Abrahamsson, T. R. et al. Low gut microbiota diversity in early infancy precedes asthma at school age. Clin. Exp. Allergy 44, 842–850. https://doi.org/10.1111/cea.12253 (2014).
Bruzzese, E. et al. Disrupted intestinal microbiota and intestinal inflammation in children with cystic fibrosis and its restoration with Lactobacillus GG: a randomised clinical trial. PLoS ONE 9, e87796. https://doi.org/10.1371/journal.pone.0087796 (2014).
Kim, H. J. et al. The microbiome of the lung and its extracellular vesicles in nonsmokers, healthy smokers and COPD patients. Exp. Mol. Med. 49, e316. https://doi.org/10.1038/emm.2017.7 (2017).
Deng, M. et al. The effect of different carbon sources on water quality, microbial community and structure of biofloc systems. Aquaculture 482, 103–110. https://doi.org/10.1016/j.aquaculture.2017.09.030 (2018).
Pankratov, T. A., Dedysh, S. N. & Zavarzin, G. A. The leading role of actinobacteria in aerobic cellulose degradation in Sphagnum peat bogs. Dokl. Biol. Sci. 410, 428–430. https://doi.org/10.1134/s0012496606050243 (2006).
Sze, M. A. et al. The lung tissue microbiome in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 185, 1073–1080. https://doi.org/10.1164/rccm.201111-2075OC (2012).
Kosiewicz, M. M., Zirnheld, A. L. & Alard, P. Gut microbiota, immunity, and disease: a complex relationship. Front. Microbiol. 2, 180. https://doi.org/10.3389/fmicb.2011.00180 (2011).
Maslowski, K. M. & Mackay, C. R. Diet, gut microbiota and immune responses. Nat. Immunol. 12, 5–9. https://doi.org/10.1038/ni0111-5 (2011).
Smith, P. M. et al. The microbial metabolites, short-chain fatty acids, regulate colonic treg cell homeostasis. Science 341, 569–573. https://doi.org/10.1126/science.1241165 (2013).
Litvak, Y., Byndloss, M. X. & Baumler, A. J. Colonocyte metabolism shapes the gut microbiota. Science https://doi.org/10.1126/science.aat9076 (2018).
Lewis, G. et al. Dietary fiber-induced microbial short chain fatty acids suppress ILC2-dependent airway inflammation. Front. Immunol. 10, 2051. https://doi.org/10.3389/fimmu.2019.02051 (2019).
Zarrinpar, A. et al. Antibiotic-induced microbiome depletion alters metabolic homeostasis by affecting gut signaling and colonic metabolism. Nat. Commun. 9, 2872. https://doi.org/10.1038/s41467-018-05336-9 (2018).
Makki, K., Deehan, E. C., Walter, J. & Backhed, F. The impact of dietary fiber on gut microbiota in host health and disease. Cell Host Microbe 23, 705–715. https://doi.org/10.1016/j.chom.2018.05.012 (2018).
Petrache, I. & Berdyshev, E. V. Ceramide signaling and metabolism in pathophysiological states of the lung. Annu. Rev. Physiol. 78, 463–480. https://doi.org/10.1146/annurev-physiol-021115-105221 (2016).
Chakinala, R. C., Khatri, A., Gupta, K., Koike, K. & Epelbaum, O. Sphingolipids in COPD. Eur. Respir. Rev. https://doi.org/10.1183/16000617.0047-2019 (2019).
Alagawany, M. et al. Omega-3 and omega-6 fatty acids in poultry nutrition: effect on production performance and health. Animals (Basel) 9, 1. https://doi.org/10.3390/ani9080573 (2019).
Duvall, M. G. & Levy, B. D. DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation. Eur. J. Pharmacol. 785, 144–155. https://doi.org/10.1016/j.ejphar.2015.11.001 (2016).
Jain, A. P., Aggarwal, K. K. & Zhang, P. Y. Omega-3 fatty acids and cardiovascular disease. Eur. Rev. Med. Pharmacol. Sci. 19, 441–445 (2015).
Simopoulos, A. P. Omega-3 fatty acids in inflammation and autoimmune diseases. J. Am. Coll. Nutr. 21, 495–505. https://doi.org/10.1080/07315724.2002.10719248 (2002).
Papamichael, M. M., Shrestha, S. K., Itsiopoulos, C. & Erbas, B. The role of fish intake on asthma in children: a meta-analysis of observational studies. Pediatr. Allergy Immunol. 29, 350–360. https://doi.org/10.1111/pai.12889 (2018).
Wood, L. G. Omega-3 polyunsaturated fatty acids and chronic obstructive pulmonary disease. Curr. Opin. Clin. Nutr. Metab. Care 18, 128–132. https://doi.org/10.1097/MCO.0000000000000142 (2015).
Hwang, Y.-Y. & Ho, Y.-S. Nutraceutical support for respiratory diseases. Food Sci. Hum. Wellness 7, 205–208. https://doi.org/10.1016/j.fshw.2018.09.001 (2018).
Zanutto, M. E., Jordao Junior, A. A., Meirelles, M. S., Favaro, R. M. & Vannucchi, H. Effect of citric pectin on beta-carotene bioavailability in rats. Int. J. Vitam. Nutr. Res. 72, 199–203. https://doi.org/10.1024/0300-9831.72.4.199 (2002).
Palafox-Carlos, H., Ayala-Zavala, J. F. & Gonzalez-Aguilar, G. A. The role of dietary fiber in the bioaccessibility and bioavailability of fruit and vegetable antioxidants. J. Food Sci. 76, R6–R15. https://doi.org/10.1111/j.1750-3841.2010.01957.x (2011).
Rodriguez-Amaya, D. B. Food carotenoids: analysis, composition and alterations during storage and processing of foods. Forum Nutr. 56, 35–37 (2003).
van Het Hof, K. H., West, C. E., Weststrate, J. A. & Hautvast, J. G. Dietary factors that affect the bioavailability of carotenoids. J. Nutr. 130, 503–506. https://doi.org/10.1093/jn/130.3.503 (2000).
Boros, L. G. et al. Submolecular regulation of cell transformation by deuterium depleting water exchange reactions in the tricarboxylic acid substrate cycle. Med. Hypotheses 87, 69–74. https://doi.org/10.1016/j.mehy.2015.11.016 (2016).
Cong, F. S. et al. Deuterium-depleted water inhibits human lung carcinoma cell growth by apoptosis. Exp. Ther. Med. 1, 277–283. https://doi.org/10.3892/etm_00000043 (2010).
Kotyk, A., Dvorakova, M. & Koryta, J. Deuterons cannot replace protons in active transport processes in yeast. FEBS Lett. 264, 203–205. https://doi.org/10.1016/0014-5793(90)80248-h (1990).
Somlyai, G. et al. Naturally occurring deuterium is essential for the normal growth rate of cells. FEBS Lett. 317, 1–4. https://doi.org/10.1016/0014-5793(93)81479-j (1993).
Somlyai, G. et al. Effect of systemic subnormal deuterium level on metabolic syndrome related and other blood parameters in humans: a preliminary study. Molecules https://doi.org/10.3390/molecules25061376 (2020).
Scheiman, J. et al. Meta-omics analysis of elite athletes identifies a performance-enhancing microbe that functions via lactate metabolism. Nat. Med. 25, 1104–1109. https://doi.org/10.1038/s41591-019-0485-4 (2019).
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M. & Altman, D. G. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 8, e1000412. https://doi.org/10.1371/journal.pbio.1000412 (2010).
Jang, J. E. et al. Protective role of endogenous plasmalogens against hepatic steatosis and steatohepatitis in mice. Hepatology 66, 416–431. https://doi.org/10.1002/hep.29039 (2017).
Song, H. E., Lee, H. Y., Kim, S. J., Back, S. H. & Yoo, H. J. A facile profiling method of short chain fatty acids using liquid chromatography-mass spectrometry. Metabolites https://doi.org/10.3390/metabo9090173 (2019).
Folch, J., Lees, M. & Sloane Stanley, G. H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497–509 (1957).
Bligh, E. G. & Dyer, W. J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911–917. https://doi.org/10.1139/o59-099 (1959).
Acknowledgements
This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (No. 2020R1A2C1008431, S.W.L.).
Author information
Authors and Affiliations
Contributions
S.W.L. conceived the study. S.W.L. and Y.O.J. contributed to the design of the study and the writing of the manuscript. Y.O.J. and S.J.K. performed the experiments. Y.O.J., O.K., S.J.K., and H.J.Y. analyzed the data. S.Y. and S.E.L. performed microbiome analysis. S.W.L., Y.O.J., S.H.L., H.J.Y., and Y.S. provided critical analysis and discussions. All authors reviewed and corrected the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Jang, Y.O., Kim, OH., Kim, S.J. et al. High-fiber diets attenuate emphysema development via modulation of gut microbiota and metabolism. Sci Rep 11, 7008 (2021). https://doi.org/10.1038/s41598-021-86404-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-021-86404-x
This article is cited by
-
Early and long-term responses of intestinal microbiota and metabolites to 131I treatment in differentiated thyroid cancer patients
BMC Medicine (2024)
-
Effect of YuPingFeng granules on clinical symptoms of stable COPD: study protocol for a multicenter, double-blind, and randomized controlled trial
BMC Complementary Medicine and Therapies (2024)
-
Associations of a plant-centered diet and lung function across early to mid-adulthood: The CARDIA Lung Study
Respiratory Research (2024)
-
Fine particulate matter aggravates smoking induced lung injury via NLRP3/caspase-1 pathway in COPD
Journal of Inflammation (2024)
-
Application of Microbiome-Based Therapies in Chronic Respiratory Diseases
Journal of Microbiology (2024)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.